Mereo BioPharma shares are trading higher after the company reported a year-over-year increase in FY23 EPS results. Also, Needham maintained a Buy rating on the stock and raised its price target from $5 to $6.

MEREO BIOPHARMA GROUP PLC -6.35%

MEREO BIOPHARMA GROUP PLC

MREO

3.98

-6.35%

Mereo BioPharma shares are trading higher after the company reported a year-over-year increase in FY23 EPS results. Also, Needham maintained a Buy rating on the stock and raised its price target from $5 to $6.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via